MDxHealth S.A.
MDXH
Pozycja w akcjach
#21620
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Cena akcji
$3.39
Ostatnia synchronizacja: 2023-12-15
Kapitalizacja rynkowa
$96.16M
Zmiana (1 dzień)
-1.73%
Zmiana (1 rok)
0.01%
Kraj
BE
Handel MDxHealth S.A. (MDXH)
Kategoria
Healthcare
Historia ceny akcji dla MDxHealth S.A. (MDXH)
Najwyższa cena zamknięcia: $3.30 dnia 2023-12-01
Najniższa cena zamknięcia: $109.85 dnia 2008-08-01
Najniższa cena zamknięcia: $109.85 dnia 2008-08-01
Historia cen akcji firmy MDxHealth S.A. od 2008 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2023 | -52.10% |
| 2022 | -33.51% |
| 2021 | 0.16% |
| 2020 | -8.63% |
| 2019 | -47.39% |
| 2018 | -49.31% |
| 2017 | -10.95% |
| 2016 | 3.69% |
| 2015 | -5.94% |
| 2014 | 20.96% |
| 2013 | 75.72% |
| 2012 | 7.83% |
| 2011 | -80.58% |
| 2008 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $686.86 | 21.10% |
US
|
|
| $232.91 | 6.79% |
US
|
|
| $400.25 | 112.88% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $175.65 | 20.41% |
US
|
